AIGH Capital Management’s Abeona Therapeutics ABEO Stock Holding History

AIGH Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.5M	Sell	2,987,000 -113,000	-4%	-$620K	1.16%	18
2026 Q1	$13.9M	Buy	3,100,000 +1,100,000	+55%	+$5.5M	1.89%	16
2025 Q4	$10.5M	Buy	+2,000,000	New	+$10.1M	2.55%	14
2024 Q1	–	Sell	-787,769	Closed	-$3.95M	–	44
2023 Q4	$3.95M	Sell	787,769 -347,483	-31%	-$1.53M	1.56%	25
2023 Q3	$4.78M	Buy	1,135,252 +496,278	+78%	+$1.88M	2.26%	17
2023 Q2	$2.58M	Sell	638,974 -13,200	-2%	-$46.2K	1.05%	24
2023 Q1	$1.84M	Hold	652,174	–	–	0.68%	34
2022 Q4	$2.01M	Buy	652,174 +511,530	+364%	+$1.91M	0.66%	32
2022 Q3	$428K	Buy	+140,644	New	+$580K	0.13%	42
2022 Q2	–	Sell	-201,004	Closed	-$1.58M	–	48
2022 Q1	$1.58M	Buy	201,004 +155,513	+342%	+$1.07M	0.39%	32
2021 Q4	$383K	Buy	+45,491	New	+$836K	0.12%	47

Other funds holding ABEO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OIA

OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AIGH Capital Management's ABEO Position: Q2 2026 in Review

AIGH Capital Management reduced its Abeona Therapeutics (ABEO) stake by 3.6% in Q2 2026, selling an estimated $620K and leaving 2,987,000 shares worth $18.5M. The position accounts for 1.16% of the portfolio, ranked #18.

AIGH Capital Management first reported a position in ABEO in Q4 2021 and has held it in 11 quarters since. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

AIGH Capital Management held 2,987,000 shares of Abeona Therapeutics worth $18.5M as of Q2 2026.
AIGH Capital Management sold 113,000 Abeona Therapeutics shares in Q2 2026, an estimated $620K.
Abeona Therapeutics made up 1.16% of AIGH Capital Management's portfolio in Q2 2026, its #18 holding.
AIGH Capital Management first reported a position in Abeona Therapeutics in Q4 2021 and has held it in 11 quarters since.
127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on AIGH Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.